Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
PMV Pharmaceuticals, Inc
Eli Lilly and Company
Terremoto Biosciences Inc.
Bristol-Myers Squibb
Arvinas Inc.
Perspective Therapeutics
Radiopharm Theranostics, Ltd
Second Life Therapeutics
Ocellaris Pharma, Inc.
Tanabe Pharma America, Inc.
BicycleTx Limited
Maastricht University Medical Center
LigaChem Biosciences, Inc.
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Incyte Corporation
NGM Biopharmaceuticals, Inc
Numab Therapeutics AG
Purple Biotech Ltd.
Cyteir Therapeutics, Inc.
Aminex Therapeutics, Inc.
NextCure, Inc.
NGM Biopharmaceuticals, Inc
Cancer Research UK
NantCell, Inc.
Compugen Ltd
Second Affiliated Hospital of Guangzhou Medical University
Innolake Biopharm
CytomX Therapeutics
Fusion Pharmaceuticals Inc.
Klus Pharma Inc.
Kineta Inc.
Incyte Corporation
Incyte Corporation
Seagen Inc.
NKGen Biotech, Inc.
Otsuka Novel Products GmbH
Centocor, Inc.
Memorial Sloan Kettering Cancer Center
Duke University